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Abstract
RNAi interference (RNAi) for insect pest control is often used to silence genes controlling vital functions, thus generating 
lethal phenotypes. Here, we propose a novel approach, based on the knockout of an immune gene by dsRNA-expressing 
bacteria as a strategy to enhance the impact of spray applications of the entomopathogen Bacillus thuringiensis (Bt). The 
target gene, Sl 102, controls the encapsulation and nodulation responses in the noctuid moth Spodoptera littoralis (Lepidop-
tera, Noctuidae). To deliver Sl 102 dsRNA, we have developed a bacterial expression system, using HT115 Escherichia coli. 
This allows a much cheaper production of dsRNA and its protection against degradation. Transformed bacteria (dsRNA-
Bac) administered through artificial diet proved to be more effective than dsRNA synthesized in vitro, both in terms of gene 
silencing and immunosuppression. This is a likely consequence of reduced dsRNA environmental degradation and of its 
protected release in the harsh conditions of the gut. The combined oral administration with artificial diet of dsRNA-Bac and 
of a Bt-based biopesticide (Xentari™) resulted in a remarkable enhancement of Bt killing activity, both on 4th and 5th instar 
larvae of S. littoralis, either when the two components were simultaneously administered or when gene silencing was obtained 
before Bt exposure. These results pave the way toward the development of novel Bt spray formulations containing killed 
dsRNA-Bac, which synergize Bt toxins by suppressing the insect immune response. This strategy will preserve the long-term 
efficacy of Bt-based products and can, in principle, enhance the ecological services provided by insect natural antagonists.
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Key message
• RNAi for insect control requires the development of 
effective delivery strategies of dsRNA.
• Bacteria expressing a dsRNA targeting an immune gene 
induce its silencing when ingested by larvae of the noc-
tuid moth Spodoptera littoralis.
• The resulting immunosuppression enhances the killing 
activity of a Bt-based biopesticide.
• These immune suppressive bacteria can be used as syn-
ergistic factors to develop more effective Bt sprays, and 
to preserve Bt efficacy.
Introduction
RNAi interference (RNAi), the sequence  specific gene 
silencing mediated by short non-coding dsRNA, that pro-
motes mRNA cleavage or repression of mRNA translation 
was first discovered by Fire et al. (1998) in their pioneer-
ing study on the nematode Caenorhabditis elegans. Since 
then, RNAi has been reported in almost all eukaryotes as 
a fine-tuned mechanism of gene regulation (Carthew and 
Sontheimer 2009; Gebert and MacRae 2019) and as an 
important component of antiviral defense barriers (Ding 
2010; Bronkhorst and van Rij 2014; Ding et al. 2018). More 
recent studies have revealed an unexpected and intense 
movement of regulative dsRNAs even between organisms 
(Knip et al. 2014). This fascinating phenomenon, called 
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“cross-kingdom RNAi,” in some cases contributes to the 
communication between plant or animal hosts and asso-
ciated pathogens, parasites or symbiotic microorganisms 
(Knip et al. 2014; Wang et al. 2015, 2017; Weiberg et al. 
2015).
The RNAi pathway has been largely exploited as a 
potent loss-of-function tool to unravel gene functions in 
animals (Housden et al. 2017), including insects (Di Lelio 
et al. 2014; Sugahara et al. 2015; Li et al. 2017, 2018; Jia 
et al. 2018; Pan et al. 2018). Interestingly, in insects the 
oral ingestion of dsRNA can trigger a silencing response 
in most body tissues (i.e., systemic RNAi), which can be 
profitably exploited for the development of RNAi-based 
control strategies against agricultural pests and pathogen 
vectors, by selectively targeting genes controlling physi-
ological and developmental pathways of vital importance 
(Joga et al. 2016; Cooper et al. 2019). RNAi-plants to con-
trol coleopteran pests have recently reached the market (Zotti 
et al. 2018) and, along with other RNAi-based biopesticides, 
are expected to become an effective alternative to chemical 
products.
Systemic RNAi is robust in Coleoptera, absent in Diptera 
and unevenly present in other insect orders (Joga et al. 2016; 
Cooper et al. 2019), such as in Lepidoptera, where occurs 
in several noctuid species (e.g., Helicoverpa and Spodop-
tera spp.) (Tian et al. 2009; Di Lelio et al. 2014; Lim et al. 
2016; Cooper et al. 2019). This paves the way toward the 
development of RNAi-based pest control strategies, which, 
however, can be profitably pursued if effective oral delivery 
methods, to overcome environmental and insect gut degra-
dation of dsRNA molecules, are developed (Yu et al. 2013; 
Joga et al. 2016; Cooper et al. 2019). Polymers currently 
being used as carriers for oral delivery of dsRNA molecules 
in Lepidoptera (He et al. 2013; Christiaens et al. 2018) are 
comparatively less effective than plants and bacteria (Zhang 
et al. 2017; Zotti et al. 2018). The idea of using bacteria 
as delivery vectors of dsRNA molecules was first proposed 
in the pioneering studies on RNAi in the bacteriophagous 
nematode C. elegans (Timmons and Fire 1998; Timmons 
et al. 2001). This proof of concept prompted studies on the 
exploitation of the bacterial delivery strategy for pest control 
purposes, in order to overcome the technical and economic 
problems associated with the use of dsRNA synthesized 
in vitro. Tian et al. (2009) first reported the efficacy of bac-
terially expressed dsRNA in the induction of systemic RNAi 
in insects, in particular in the lepidopteran pest Spodoptera 
exigua. Several other studies have clearly shown that bacte-
rial delivery (1) is cost-effective, (2) protects dsRNA mol-
ecules against degradation and (3) allows the development 
of new plant protection products/tools (Kim et al. 2015; Lim 
et al. 2016; Zhu et al. 2016; Ganbaatar et al. 2017; Israni and 
Rajam 2017; Vatanparast and Kim 2017; Wang et al. 2018).
We have recently shown that RNAi-mediated silenc-
ing of an immune gene in S. littoralis larvae, obtained by 
oral microinjection of dsRNA synthesized in vitro, results 
in a significant enhancement of insect mortality triggered 
by Bacillus thuringiensis (Bt) (Caccia et al. 2016; Di Lelio 
et al. 2019). This evidence sheds light on Bt killing mecha-
nism (Caccia et al. 2016; Di Lelio et al. 2019) and paves the 
way toward the development of novel pest control strate-
gies based on immunosuppression as a tool to enhance the 
impact of entomopathogens. Here, we contribute to this 
goal by exploring the use of bacteria as delivery vectors of 
dsRNAs targeting the immune system, in order to enhance 




Spodoptera littoralis larvae were reared on artificial diet 
(41.4 g/l wheat germ, 59.2 g/l brewer’s yeast, 165 g/l corn 
meal, 5.9 g/l ascorbic acid, 1.53 g/l benzoic acid, 1.8 g/l 
methyl 4-hydroxybenzoate and 29.6 g/l agar), at 25 ± 1 °C 
and 70 ± 5% RH, with 16:8 h light–dark period.
In vitro synthesis of Sl 102 dsRNA
Total RNA was extracted from haemocytes of S. littora-
lis 6th instar larvae, retro-transcribed with the  Ambion® 
 RETROscript® Kit (Thermo Fisher Scientific), and a 580 bp 
long Sl 102 cDNA fragment was obtained by PCR (Sl 102 
F primer: TAC ATC CAA GTA AAT TTG CAA GGC; Sl 102 
R primer: GGC CCA GAA CAT TCT CAC CTC). This cDNA 
fragment was used as template for a nested PCR reaction, 
performed with primers containing at their 5′ ends the T7 
polymerase promoter sequence (T7-Sl 102 F: TAA TAC 
GAC TCA CTA TAG GGA GAA CCT CCT GAG CGT GCC 
TGA; T7-Sl 102 R: TAA TAC GAC TCA CTA TAG GGA 
GGG AGT GCT GCT TCA GAA TCA T). The resulting PCR 
product served as template to synthesize a dsRNA (469 bp 
long), using the  Ambion®  MEGAscript® RNAi Kit (Thermo 
Fisher Scientific), according to the manufacturer’s instruc-
tions. Synthesized dsRNA was quantified by measuring its 
absorbance at 260 nm with a Varioskan Flash Multimode 
Reader (Thermo Fisher Scientific), and purity was evaluated 
by assessing 260/280 nm absorbance ratios. dsRNA was run 
on 1% agarose gels to check its integrity.
A GFP dsRNA, used in control experiments, was simi-
larly produced starting from the cloning vector  pcDNA® 
3.1/CT-GFP  TOPO® (Thermo Fisher Scientific), which was 
used as template for a PCR reaction, performed with prim-
ers containing at their 5′ ends the T7 polymerase promoter 
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sequence (T7-GFP F: TAA TAC GAC TCA CTA TAG GGA 
GAG TGG AGA GGG TGA AGGTG; T7-GFP R: TAA TAC 
GAC TCA CTA TAG GGA GGG GCA GAT TGT GTC GACAG). 
The resulting PCR product served as template to synthesize 
a dsRNA (531 bp long), as described above.
Production of transformed HT115 Escherichia coli 
expressing Sl 102 dsRNA
A L4440 recombinant vector, encoding Sl 102 or GFP 
(negative control) dsRNA molecules, was produced with the 
 Gateway® cloning technology and used to transform HT115 
E. coli cells.
Cloning of Sl 102 and transformation of bacteria 
for Sl 102 dsRNA production
Total RNA extracted from S. littoralis haemocytes was 
subjected to retro-transcription  (Ambion®  RETROscript® 
Kit, Thermo Fisher Scientific) and, then, used for PCR 
amplification of Sl 102, with specific primers (Sl 102 F: 
CAC CAA CCT CCT GAG CGT GCCT; Sl 102 R: CGG AGT 
GCT GCT TCA GAA TC). A GFP fragment, used in con-
trol experiments, was amplified from the cloning vector 
 pcDNA® 3.1/CT-GFP  TOPO® (Thermo Fisher Scientific), 
which served as template for a PCR reaction, using specific 
primers (GFP F: CAC CAG TGG AGA GGG TGA AGGTG; 
GFP R: GGG CAG ATT GTG TCG ACA G).
PCR products were ligated into the pENTR/D®-TOPO® 
vector (Thermo Fisher Scientific), compatible with the 
 Gateway® technology, and the vector was introduced into 
chemically competent One  Shot® TOP10 E. coli cells that 
were plated on LB agar. Plasmids from colonies grown over-
night were extracted (Charge-Switch-Pro plasmid miniprep 
kit, Thermo Fisher) and sequenced. Sl 102 and GFP frag-
ments were cloned into a  Gateway®-compatible L4440 vec-
tor, constructed by using the  Gateway® vector conversion 
system, ligating a blunt-ended cassette containing attR sites 
flanking the ccdB gene and the chloramphenicol resistance 
gene. Cloning was performed using a transposition reac-
tion catalyzed by the LR  clonase® enzyme (Thermo Fisher 
Scientific).
The resulting recombinant plasmids were introduced into 
competent E. coli HT115 cells that lack RNase III and can 
be induced to express T7 polymerase in the presence of iso-
propyl β-d-1-thiogalactopyranoside (IPTG) (Newmark et al. 
2003; Timmons et al. 2001; Timmons and Fire 1998).
To produce dsRNA, the transformed bacteria were grown 
in the liquid broth Luria–Bertani (LB), containing 100 μg/
ml ampicillin and 12.5 μg/ml tetracycline, at 37 °C for 16 h, 
under continuous shaking (250 rpm). Then, 5 ml of cultured 
broth was added to 500 ml of fresh LB medium and allowed 
to grow until  OD600 = 0.6–0.7. Expression of T7 RNA 
polymerase gene, for dsRNA overexpression, was induced 
by the addition of 1 mM IPTG to transformed bacteria, 
which were incubated overnight at 37 °C, under continuous 
shaking. Bacteria producing dsRNA targeting Sl 102 gene 
or producing GFP dsRNA are hereafter denoted as Sl 102 
dsRNA-Bac and GFP dsRNA-Bac, respectively.
Bacterial cells were collected by centrifugation at 
12,000×g for 1 min at 4 °C and suspended in phosphate-
buffered saline (PBS, 137 mM NaCl, 2.7 mM KCl, 4.3 mM 
 Na2HPO4, 1.4 mM  KH2PO4, pH 7.4). To kill the bacteria to 
be used in all feeding bioassays and to facilitate the release 
of dsRNA, a sonication protocol was developed. Bacterial 
suspensions were subjected to an increasing number of 
sonication cycles on ice with an ultrasound homogeniser 
(Sonoplus, Bandelin), adopting decreasing time intervals 
between cycles. The bacteria viability after the treatments 
was evaluated by plating the resulting sonicated suspension 
on Petri dishes containing LB agar (supplied with 100 μg/ml 
ampicillin and 12.5 μg/ml tetracycline). Complete mortality 
was obtained with ten cycles of sonication (59 s on/2 s off, 
95% amplitude).
qRT‑PCR absolute quantification of Sl 102 dsRNA 
produced by bacteria
dsRNA produced by E. coli was extracted from cell pellets, 
using the protocol by Timmons et al. (2001). The quantifi-
cation was performed by quantitative real-time PCR using 
Applied Biosystems™ SYBR™ Green master mix (Thermo 
Fisher Scientific). The quantity of dsRNA was determined 
by relating its threshold value (CT) values to an established 
standard curve, according to the absolute quantification 
method (Rutledge and Côté 2003).The standard curve for 
Sl 102 dsRNA was established by plotting the logarithm of 
6 10-fold dilutions of a starting solution containing 300 ng/
µl of L4440  Gateway® vector with insert, against the cor-
responding CT value. The PCR efficiency (E = 98.274%) 
was calculated on the base of the slope and the coefficient 
of correlation (R2) of the standard curve (slope = − 3.365, 
y intercept = 13.540, R2 = 0.997), according to the follow-
ing formula: E = 10(−1/slope) − 1. The standard curve for GFP 
dsRNA was similarly established, by plotting the logarithm 
of 6 10-fold dilutions of a starting solution containing 
200 ng/µl of L4440  Gateway® vector with insert, against 
the corresponding CT. The PCR efficiency (E = 104.0477%) 
was calculated on the base of the slope and the correlation 
coefficient (R2) of the standard curve (slope = − 3.229, y 
intercept = 17.650, R2 = 0.984), according to the following 
formula: E = 10(−1/slope) − 1.
All primer pairs were designed using Primer Express 
3.0 software (Life Technologies), following the standard 
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procedure. Negative controls (water) were included in each 
run of the qRT-PCR.
Oral administration of dsRNA to Spodoptera littoralis 
larvae
To assess the efficiency of dsRNA delivery through the use 
of sonicated bacteria, S. littoralis larvae were orally treated 
with Sl 102 dsRNA-Bac, using two different protocols. In a 
first set of experiments, dsRNA-Bac was delivered by gav-
age with a microsyringe, as previously described (Di Lelio 
et al. 2014; Caccia et al. 2016). Briefly, newly molted S. lit-
toralis 4th instar larvae were anaesthetized on ice and 1 µl 
of Sl 102 dsRNA-Bac (GFP dsRNA-Bac in controls) solu-
tion (corresponding to 45 ng of dsRNA) was poured into 
the lumen of the foregut by means of a Hamilton Microliter 
syringe (1701RNR 10 µl, gauge 26 s, length 55 mm, needle 
3). This treatment was repeated three times, at 24 h intervals. 
A group of larvae that received 1 µl of a solution of Sl 102 
dsRNA (45 ng/µl) synthesized in vitro (or GFP dsRNA in 
controls) acted as positive control, since this dose proved 
to be effective in the induction of gene silencing (Di Lelio 
et al. 2014).
The second protocol was developed for feeding bioas-
says on artificial diet. Newly molted 4th instar larvae were 
isolated in multi-well plastic trays (Bio-Rt-32, Frontier Agri-
cultural Sciences), containing artificial diet, covered with 
perforated plastic lids (Bio-Cv-4, Frontier Agricultural Sci-
ences), and maintained under the rearing conditions reported 
above. The experimental larvae, for 3 consecutive days, at 
24 h intervals, were offered a small piece of diet with the 
upper surface (0.25 cm2) uniformly overlaid with 1 μl of a 
solution of Sl 102 dsRNA synthesized in vitro (45 ng/µl) 
or a Sl 102 dsRNA-Bac suspension containing 45, 100 and 
200 ng of dsRNA. Controls received GFP dsRNA synthe-
sized in vitro or GFP dsRNA-Bac. Experimental larvae were 
maintained on artificial diet before and after the 3 admin-
istrations of dsRNA synthesized in vitro or of dsRNA-Bac 
suspension, which were overlaid on a small amount of the 
same diet, which was completely consumed in about 1 h.
Silencing efficiency was evaluated by qRT-PCR, as 
described below, 24 h after the last dsRNA administration, 
and the impact on immune competence was assessed by 
measuring the encapsulation index of injected chromatog-
raphy beads, as previously described (Di Lelio et al. 2014).
qRT‑PCR relative quantification of Sl 102 
transcription
Total RNA was extracted from haemocytes of S. littoralis 
larvae, using  TRIzol® reagent (Thermo Fisher Scientific), 
according to manufacturer’s instructions. Gene transcription 
level was assessed by qRT-PCR, which was carried out by 
using Sl 102 gene-specific primers (Sl 102 RT F: GGC GGT 
GTC GTC GTC GAT TATG; Sl 102 RT R: GAG CGA GGA 
AAT GTT CAA T), designed to detect a segment of the Sl 
102 mRNA external to the segment targeted by the dsRNA. 
S. littoralis β-actin gene (Accession Number Z46873) was 
used as endogenous control for RNA loading (β-actin RT 
F: CGT CTT CCC ATC CAT CGT; β-actin RT R: CCT TCT 
GAC CCA TAC CAA CCA). All primers were designed using 
Primer Express, version 1.0 software (Applied Biosystems). 
The level of mRNA was measured by one-step qRT-PCR 
using the Applied Biosystems™ SYBR™ Green master mix 
(Thermo Fisher Scientific), according to the manufacturer’s 
instructions. The amount of the target transcript relative to 
the endogenous control was determined using the  2-ΔΔCT 
method (Livak and Schmittgen 2001; Pfaffl 2001; Pfaffl et al. 
2002). For validation of the ΔΔCT method, the difference 
between the CT value of Sl 102 and the CT value of β-Actin 
transcripts [ΔCT = CT (Sl 102) − CT (β-actin)] was plotted 
versus the log of 10-fold serial dilutions (5000, 500, 50, 5 
and 0.5 ng) of the purified RNA samples. The plot of log 
total RNA input versus ΔCT displayed a slope less than 0.1 
(slope = 0.0154, R2 = 0.0776), indicating that the efficiencies 
of the 2 amplicons were approximately equal.
Bioassays with Xentari™
Three different feeding bioassays on S. littoralis larvae were 
carried out, in order to evaluate the impact of Sl 102 gene 
silencing on the killing activity of the entomopathogen 
Bacillus thuringiensis (Bt). Preliminary trials were per-
formed in order to identify sublethal Bt doses (i.e., with no 
or very low effect on mortality and only moderately affect-
ing the speed of larval development), which were 9 μg/cm2 
and 12 μg/cm2 for 4th and 5th instar larvae, respectively. 
The use of this Bt dose allowed the assessment of any 
increase in the mortality rate caused by the RNAi-induced 
immunosuppression.
In the first type of bioassay (sequential treatment), 4th 
instar larvae were fed for 3 days with artificial diet over-
laid with Sl 102 dsRNA-Bac (or GFP dsRNA-Bac) (cor-
responding to 200 ng of dsRNA), as described above. Four 
hours after the administration of the last dsRNA dose, the 
experimental larvae, which in the meantime attained the 5th 
instar, were fed with artificial diet overlaid with a dose of 
12 μg/cm2 of Xentari™ (Valent BioSciences), a bioinsec-
ticide based on Bt subsp. aizawaii, containing several Cry 
toxins (Cry1Aa, Cry1Ab, Cry1Ca, Cry1 Da and Cry2Ab). 
This treatment with Xentari™ was repeated 3 times, at 24 h 
interval, and, since Xentari™ was suspended in water, con-
trol diet was overlaid with water.
A second bioassay was designed to evaluate the effect of 
the simultaneous administration of dsRNA and Xentari™, 
to better simulate field spraying with a product containing 
Journal of Pest Science 
1 3
both components. Newly molted 4th instar larvae were fed 
with artificial diet overlaid with Sl 102 dsRNA-Bac (or GFP 
dsRNA-Bac) (corresponding to 200 ng of dsRNA), as previ-
ously described, and, after 4 h, Xentari™ was administered 
at a dose of 9 μg/cm2. This was done for 3 days. Controls 
were treated with water. The same experiment was per-
formed with newly molted 5th instar larvae, using a dose of 
Xentari™ of 12 μg/cm2. Mortality was daily recorded for 
8 days, when the experimental larvae were weighed.
Statistical analysis
Data were analyzed using GraphPad Prism, version 6.0b. 
Encapsulation assay and Sl 102 gene expression in gavage 
experiments were analyzed using the unpaired Student’s 
t test, and larval weight was analyzed using One-Way 
ANOVA and Tukey’s multiple-comparison post hoc test. 
When ANOVA assumptions were not fulfilled, nonparamet-
ric Kruskal–Wallis ANOVA followed by Dunn’s multiple 
comparisons post hoc test was used. Sl 102 gene expres-
sion in feeding experiments was analyzed using Three-Way 
ANOVA to assess the effect of dsRNA treatment, produc-
tion protocol and concentration. Levene’s test was used to 
test the homogeneity of variance. When necessary, trans-
formation of data was carried out to meet the assumptions 
of normality and homoscedasticity. When significant effects 
were observed (P < 0.05), the Bonferroni’s post hoc test was 
used to compare mean values. Survival curves of S. littora-
lis larvae were compared using Kaplan–Meier and log-rank 
analyses. Normality of data was checked with Shapiro–Wilk 
test and Kolmogorov–Smirnov test, while homoscedasticity 
was tested with Levene’s test and Bartlett’s test.
Results
Production of bacteria expressing Sl 102 dsRNA
To produce bacteria expressing dsRNA, a partial sequence 
of Sl 102 gene (or GFP in controls) was inserted into L4440 
vector, using the rapid and highly efficient  Gateway® 
recombinational cloning system (Landy 1989). Briefly, the 
PCR product of the fragment of interest (Sl 102 or GFP as 
control) was inserted in a donor vector to create the attL-
containing entry clone. This latter has been used in a sec-
ond recombination reaction with an attR-destination vector 
(L4440 vector properly converted into a  Gateway® destina-
tion vector), to create an attB-containing expression clone 
used to transform HT115 E. coli cells (see Fig. 1a). Produc-
tion of dsRNA occurs thanks to attB site-specific attachment 
sites on E. coli chromosome, and dsRNA overexpression, 
under the T7 promoters, is induced by IPTG addition. The 
amount of the dsRNA produced by bacteria (Fig. 1b) has 
been quantified by absolute qRT-PCR (Fig. 1c).
Sl 102 dsRNA-Bac produced were sonicated in order 
to disrupt the cell wall and to facilitate the release of 
dsRNA in the insect gut. Moreover, the use of killed bac-
teria is an essential requirement for their safe release in the 
environment.
Silencing efficiency and immune suppressive effects 
of Sl 102 dsRNA‑Bac
We first assessed RNAi efficiency and associated immuno-
suppression of Sl 102 dsRNA-Bac by comparing their silenc-
ing effect with that induced by Sl 102 dsRNA synthesized 
in vitro, adopting a protocol previously described (Di Lelio 
et al. 2014). Thus, Sl 102 dsRNA-Bac and Sl 102 dsRNA 
produced in vitro (hereafter denoted as Sl 102 dsRNA-synt) 
(GFP dsRNA-Bac and GFP dsRNA-synt were used as con-
trols, respectively) were orally administered, for 3 days to 
4th instar S. littoralis larvae, by gavage with a microsyringe. 
Since 45 ng/µl is the lowest dose of Sl 102 dsRNA-synt 
inducing maximal down-regulation of Sl 102 gene (Di Lelio 
et al. 2014), an equal amount of dsRNA, measured by abso-
lute qRT-PCR quantification (Fig. 1c), was administered as 
Sl 102 dsRNA-Bac.
This experiment demonstrated that both dsRNA-synt and 
Sl 102 dsRNA-Bac are associated with a significant level of 
silencing of the target gene compared to controls (Student’s 
t test: for dsRNA-synt t = 18.282, df = 28, P < 0.0001, for 
dsRNA-Bac t = 16.621, df = 28, P < 0.0001) (Fig. 2), even 
though dsRNA-synt was by far more active than dsRNA-
Bac. Since Sl 102 gene is involved both in the nodulation of 
microorganisms and in the encapsulation of large parasites 
(e.g., parasitoid eggs, nematodes) (Falabella et al. 2012; Di 
Lelio et al. 2014; Caccia et al. 2016), which are immune 
reactions sharing functional similarities (Lavine and Strand 
2002), we used the encapsulation response against chroma-
tography beads as a measure of immune suppression induced 
by Sl 102 silencing. Indeed, gene knockout was associated 
with a significant impairment of encapsulation response 
by haemocytes of silenced larvae, for both types of dsR-
NAs (Student’s t test: for dsRNA-synt t = 118.64, df = 28, 
P < 0.0001, for dsRNA-Bac t = 63.508, df = 28, P < 0.0001) 
(Fig. 3). 
To explore whether the bacterial delivery of dsRNA 
confers protection against degradation, Sl 102 dsRNA-Bac 
and Sl 102 dsRNA-synt were overlaid on artificial diet 
and separately offered to S. littoralis larvae, in order to 
compare their silencing efficiency and immune suppressive 
activity, at different experimental doses. The transcription 
level of the target gene was significantly affected by the 
dsRNA treatment (Three-Way ANOVA: F1,140 = 567.493; 
P < 0.0001), exhibited a more pronounced down-regulation 
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Fig. 1  Production of HT115 Escherichia coli cells expressing 
dsRNA. a Cloning and transformation protocol. b Expression of 
dsRNA by transformed HT115 E. coli; total RNA samples were sub-
jected to RT-PCR, and amplicons were resolved on 1% agarose gel. 
Primers specific for Sl 102 or GFP genes produced amplicons of the 
expected size in HT115 E. coli expressing Sl 102 dsRNA or GFP 
dsRNA, respectively (lanes 1 and 2), whereas the same primers did 
not generate any amplicon when total RNA from non  transformed 
bacteria was used (wt HT115) (lanes 3 and 4). c Calibration curves 
used for qRT-PCR absolute quantification of Sl 102 and GFP dsRNA 
present in E. coli suspensions used in the bioassays
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when dsRNA-Bac was used (Three-Way ANOVA: 
F1,140 = 152.170; P < 0.0001) and was positively correlated 
with the experimental dose used (Three-Way ANOVA: 
F2,140 = 49,155; P < 0.0001) (Fig. 2). The encapsulation 
reaction showed a similar pattern of variation (Three-Way 
ANOVA: dsRNA treatment F1,124 = 1350,724, P < 0.0001; 
dsRNA production F1,124 = 27.604, P < 0.0001; dsRNA 
dose F2,124 = 26.472, P < 0.0001) (Fig. 3).
Fig. 2  Transcript levels of Sl 102 gene in S. littoralis 4th instar lar-
vae orally treated for 3  days with dsRNA. The Sl  102 gene was 
down-regulated upon ingestion of Sl  102 dsRNA administered by 
oral gavage, both in the case of dsRNA synthesized in vitro (Sl 102 
dsRNA-synt) and suspensions of sonicated bacteria expressing Sl 102 
dsRNA (Sl  102 dsRNA-bac). Delivery with artificial diet showed a 
silencing response that was dose-dependent and more pronounced 
when bacteria were used as delivery vectors. GFP dsRNA synthe-
sized in vitro and bacteria expressing GFP dsRNA were used in con-
trol experiments. The values reported are the mean ± standard errors 
(*P < 0.0001, Student’s t test)
Fig. 3  Encapsulation assay in S. littoralis 4th larvae treated for 3 days 
with Sl 102 dsRNA synthesized in vitro (Sl 102 dsRNA-synt) or trans-
formed HT115 E. coli expressing Sl 102 dsRNA (Sl 102 dsRNA-bac). 
Chromatography beads injected into the body cavity of control larvae 
were encapsulated and melanized (a). On the contrary, the efficiency 
of encapsulation was lower in silenced larvae, independently from the 
dsRNA administration method (gavage or with artificial diet) (b). The 
encapsulation index was affected by oral delivery method and, in the 
case of oral administration on artificial diet, by dsRNA quantity. GFP 
dsRNA synthesized in vitro and bacteria expressing GFP dsRNA were 
used in control experiments. The values reported are the mean ± stand-
ard errors (*P < 0.0001, Student’s t test)
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Sl 102 dsRNA‑Bac enhance the killing activity 
of Bacillus thuringiensis
The induction of effective immune suppressive RNAi by 
Sl 102 dsRNA-Bac prompted us to assess their poten-
tial in enhancing the efficacy of a Bt-based biopesticide 
(Xentari™).
In a first set of experiments (sequential treatments), 4th 
instar S. littoralis larvae were fed with artificial diet over-
laid with Sl 102 dsRNA-Bac for 3 days, as described above 
for gavage experiments. Four hours after the last dsRNA 
treatment, Xentari™ was administered to larvae with the 
artificial diet for 3 subsequent days. Xentari™ induced 
a significantly higher mortality only in larvae fed with 
Sl 102 dsRNA-Bac (log-rank test: Chi-square = 172.3, 
df = 3, P < 0.0001) (Fig. 4a) and determined a significant 
weight reduction in the surviving larvae (Kruskal–Wallis: 
KW = 95.08; P < 0.0001) (Fig. 4b), which completely failed 
to pupate.
A second set of experiments was performed to test 
the efficacy of the simultaneous administration of Sl 102 
dsRNA-Bac and Xentari™. This experiment was designed 
to reproduce more closely the possible effects of a field 
application of both active ingredients (dsRNA and Bt). 
The results obtained, both with 4th and 5th instar lar-
vae, clearly showed that simultaneous administration of 
Fig. 4  Bioassay with S. littoralis 4th instar larvae exposed to dsRNA 
before Bt treatment. Newly molted larvae were treated for 3  days 
with artificial diet layered with transformed HT115 E. coli express-
ing Sl 102 dsRNA (Sl 102 dsRNA-Bac, corresponding to 200 ng of 
dsRNA) and then with 12 µg/cm2 of Xentari™ for 3 more days (see 
“Materials and methods” section for experimental details). Survival 
was monitored until day 8 (a), when the weight was assessed on the 
surviving experimental larvae (b). Bacteria expressing GFP dsRNA 
were used in control experiments. The timing of the treatments is 
indicated with arrows. The values reported are the mean ± standard 
errors (in a *P < 0.0001 based on log-rank test; in b different letters 
denote statistical difference based on Kruskal–Wallis test, followed 
by Dunn’s multiple-comparison post hoc test)
Fig. 5  Bioassay with S. littoralis 4th instar larvae simultaneously 
exposed to dsRNA and Bt. Newly molted larvae were treated for 
3  days with artificial diet layered with transformed HT115 E. coli 
expressing Sl  102 dsRNA (Sl  102 dsRNA-Bac, corresponding to 
200 ng of dsRNA) and with 9 µg/cm2 of Xentari (see “Materials and 
methods” section for experimental details). Survival was monitored 
until day 8 (a) when the weight was assessed on the surviving experi-
mental larvae (b). Bacteria expressing GFP dsRNA were used in con-
trol experiments. The timing of the treatments is indicated by arrows 
The values reported are the mean ± standard errors (in a **P < 0.0001 
and *P < 0.0046 based on log-rank test; in b different letters denote 
statistical difference based on Kruskal–Wallis, followed by Dunn’s 
multiple comparisons post hoc test)
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Sl 102 dsRNA-Bac and Xentari™ caused a significantly 
higher mortality in Sl 102-silenced larvae compared to 
controls (Figs.  5a, 6a)  (log-rank test 4th instar larvae: 
Chi-square = 49.02; df = 3; P < 0.0001; log-rank test 5th 
instar larvae: Chi-square = 156.6; df = 3; P < 0.0001) and 
had a significant impact on body weight both of 4th instar 
(Kruskal–Wallis: KW = 65.96; P < 0.0001) and 5th instar 
larvae (Kruskal–Wallis: KW = 135.1; P < 0.0001) (Figs. 5b, 
6b), which completely failed to pupate. 
Discussion
RNAi-based control strategies of insect pests offer new 
opportunities for the development of sustainable Integrated 
Pest Management plans, due to their specificity and reduced 
or null effect on nontarget species. This potential has been 
already unlocked by the recent introduction on the market 
in North America of genetically manipulated maize plants, 
which express dsRNA targeting the coleopteran species Dia-
brotica virgifera (Zotti et al. 2018). The development of this 
novel plant protection tool has been undoubtedly favoured by 
the high RNAi efficiency in Coleoptera. It would be desira-
ble to further expand the reach of this insect control strategy 
by hitting pest species in other insect orders of remarkable 
economic importance, such as Lepidoptera. Although effi-
ciency of RNAi response in Lepidoptera varies among spe-
cies and depends on the efficiency of the delivery method, 
Helicoverpa and Spodoptera spp. have proved to be quite 
susceptible to orally administered dsRNA, which may trig-
ger a systemic RNAi response (Tian et al. 2009; Di Lelio 
et al. 2014; Lim et al. 2016; Cooper et al. 2019).
In a previous study, we have shown that immune impair-
ment of S. littoralis larvae, induced by oral administration 
of dsRNA molecules, causes an increase of susceptibility to 
the entomopathogen B. thuringiensis and accounts for the 
key importance of septicaemia in the killing activity of this 
biocontrol agent (Caccia et al. 2016). This proof of concept 
allows the development of novel pest control strategies aim-
ing to enhance the impact of entomopathogens by RNAi-
mediated silencing of immune genes. However, to pursue 
this goal, it is essential to develop RNAi delivery strategies 
for field applications, which are efficient, safe and economi-
cally sustainable. In the present study, we have explored the 
use of bacteria as potential delivery vectors of dsRNA target-
ing insect immune genes and evaluated their impact on the 
efficacy of a Bt-based commercial product (Xentari™) used 
for Spodoptera spp. control.
We produced dsRNA-expressing E. coli bacteria, taking 
advantage of the  Gateway® recombinational cloning sys-
tem (Hartley et al. 2000; Walhout et al. 2000; Reboul et al. 
2001).
The  Gateway® technology allowed us the transformation 
of E. coli cells by a simple two-step method that exploits 
specific vectors and recombination enzymes. This standard-
ized and high-fidelity method proved to be time-saving and 
convenient for our purposes and may represent the approach 
of choice for the production of large amounts of dsRNA and 
large-scale screenings of RNAi targets.
Bacteria expressing Sl 102 dsRNA were effective in 
silencing the target gene, even though to a reduced extent 
compared to dsRNA-synt, and in the induction of immu-
nosuppression when injected directly into the oral cavity 
Fig. 6  Bioassays with S. littoralis 5th instar larvae simultaneously 
exposed to dsRNA and Bt. Newly molted larvae were treated for 
3  days with artificial diet layered with transformed HT115 E. coli 
expressing Sl  102 dsRNA (Sl  102 dsRNA-Bac, corresponding to 
200  ng of dsRNA) and with 12  µg/cm2 of Xentari (see “Materials 
and methods” section for experimental details). Survival was moni-
tored until day 8 (a), when the weight was assessed on the surviv-
ing experimental larvae (b). Bacteria expressing GFP dsRNA were 
used in control experiments. The timing of the treatments is indicated 
by arrows. The values reported are the mean ± standard errors (in a 
*P < 0.0001 based on log-rank test; in b different letters denote sta-
tistical difference based on Kruskal–Wallis test followed by Dunn’s 
multiple-comparison post hoc test)
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of S. littoralis larvae (gavage); in contrast, it is of interest 
to note that Sl 102 dsRNA-Bac showed a higher efficacy, 
compared to Sl 102 dsRNA-synt, when orally administered 
with artificial diet (Figs. 2, 3). The level of RNAi-induced 
gene silencing by Sl 102 dsRNA-Bac, along with the altera-
tion of the encapsulation response by haemocytes, showed 
a clear dose-dependent response. Comparatively, naked 
dsRNA synthesized in vitro was less effective when admin-
istered with the feeding substrate. Indeed, at all experimen-
tal doses considered, the decrease of the transcript level 
and the encapsulation index induced by dsRNA-synt were 
always less evident than those observed upon ingestion of Sl 
102 dsRNA-Bac. This evidence further corroborates previ-
ous reports indicating that the bacterial envelope protects 
dsRNA molecules against degradation (both environmental 
and inside the insect gut) and likely allows a more prolonged 
presence/release of dsRNA (Yang and Han 2014; Kim et al. 
2015; Lim et al. 2016; Vatanparast and Kim 2017).
The oral efficiency of bacterial-delivered dsRNA target-
ing Sl 102 gene prompted us to assess their use for enhanc-
ing the virulence of entomopathogens. Our results clearly 
demonstrate that the immunosuppression induced by Sl 102 
dsRNA-Bac strongly synergizes Bt-based bioinsecticides. 
Indeed, these bacterial cells administered with the feed-
ing substrate to S. littoralis larvae were able to enhance the 
mortality induced by Bt, regardless of previous or simul-
taneous administration of dsRNA and of the experimental 
larval stage treated. However, Bt exposure of larvae already 
showing gene silencing seems to have an impact on mortal-
ity slightly higher than that observed in response to concur-
rent administration of dsRNA and Bt, whichever is the instar 
treated. Indeed, the already-established immunosuppression 
likely favors a more rapid spread of bacterial septicaemia.
Bt sprays used to control lepidopteran larvae contain mix-
tures of Cry1A and Cry2A toxins, since they are based on 
spores and crystals produced by the kurstaki and aizawaii 
strains (Lacey et al. 2015). The toxin miscellaneous in these 
formulations retards but cannot avoid the development of 
resistance under strong selective pressure in the field (Lacey 
et al. 2015; Peralta and Palma 2017). Moreover, a major con-
cern threatening their use is generated by the decrease in the 
efficacy of Bt sprays on mature larvae and as a consequence 
of reiterated exposure to Bt toxins of species with multi-
ple generations across the growing season (Navon 2000; 
Janmaat and Myers 2003; Cory 2017). To alleviate these 
problems, several molecules able to improve Bt efficacy 
have been found (e.g., proteins that improve toxin produc-
tion by the bacteria and agents that enhance permeability 
of the peritrophic matrix and facilitate toxin accumulation 
near the binding sites) (Xu et al. 2001; Mohan et al. 2008; 
Fang et al. 2009) and included in Bt formulations to enhance 
their efficacy. Our results further contribute to the goal of 
enhancing the impact and the long-term efficacy of Bt spray 
formulations, by impairing the immune response of the 
insect, which is essential in counteracting the septicaemia 
induced by Bt toxins.
Here, we demonstrate that the insecticide activity of B. 
thuringiensis, one of the most widely used biopesticides, can 
be enhanced modulating the immune competence of the tar-
get pest. From a theoretical point of view, the induction of a 
reduced immune competence in the target pest appears to be 
ecologically more sustainable as it can enhance the ecologi-
cal services provided by natural antagonists. Indeed, such an 
approach will promote the establishment and proliferation of 
biological control agents, rather than favoring their dispersal 
as a consequence of a treatment directly killing the target 
pest and reducing its density.
In conclusion, the oral delivery of Sl 102 dsRNA-bac to 
S. littoralis larvae along with the food triggers a systemic 
RNAi response and a consistent immune suppression. Thus, 
immune suppressive dsRNAs vectored by bacteria may be 
exploited as synergistic factors in novel Bt sprays and to 
preserve the insecticidal activity of B. thuringiensis.
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